Hexagon Nutrition debuts on bourses with modest 6% GMP after 54x subscription

Research-based nutrition firm Hexagon lists today on NSE/BSE following a strong 54x oversubscription, led by NII at 162x and QIB at 20x. GMP of Rs 2.75 over the Rs 45 issue price signals a muted 6.11% listing pop. Backed by FY25 revenue of Rs 331 cr and PAT of Rs 24.4 cr across plants in Nasik, Chennai and Thoothukudi.

— Source publishedFri, 12 Jun, 2026, 09:14 IST·First seen Fri, 12 Jun, 2026, 09:52 IST·Source NDTV Profit

What happened

Hexagon Nutrition, a research-based nutrition company making micronutrient premixes and clinical foods, debuts on NSE/BSE today after 54x subscription. GMP of

Key facts

  • GMP Rs 2.75
  • listing price Rs 47.75
  • 6.11% gain
  • 54x subscription
  • QIB 20x
  • NII 162x
  • RII 27x
  • FY25 income Rs 331.29 cr
  • FY25 PAT Rs 24.38 cr
  • 358 distributors
  • 500 employees

Why this matters

Hexagon's public debut at a research-backed nutrition positioning creates a benchmarked comparable for adjacent functional-food and clinical-nutrition assets, opening a window for strategic tuck-ins or partnership conversations while valuations are freshly anchored.